loadpatents
Patent applications and USPTO patent grants for Futatsugi; Kentaro.The latest application filed is for "glp-1 receptor agonists and uses thereof".
Patent | Date |
---|---|
GLP-1 Receptor Agonists and Uses Thereof App 20210332034 - Aspnes; Gary Erik ;   et al. | 2021-10-28 |
Diacylglycerol Acyl Transferase 2 Inhibitors App 20210309646 - Boehm; Markus ;   et al. | 2021-10-07 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors App 20210309644 - Dowling; Matthew ;   et al. | 2021-10-07 |
Diacylglycerol acyl transferase 2 inhibitor Grant 11,065,249 - Edmonds , et al. July 20, 2 | 2021-07-20 |
Diacylglycerol acyl transferase 2 inhibitors Grant 11,034,678 - Boehm , et al. June 15, 2 | 2021-06-15 |
GLP-1 Receptor Agonists and Uses Thereof App 20210163455 - Aspnes; Gary Erik ;   et al. | 2021-06-03 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Grant 10,988,463 - Dowling , et al. April 27, 2 | 2021-04-27 |
Diacylglycerol Acyl Transferase 2 Inhibitor App 20210100798 - Edmonds; David James ;   et al. | 2021-04-08 |
Diacylglycerol Acyl Transferase 2 Inhibitor App 20210100796 - Edmonds; David James ;   et al. | 2021-04-08 |
GLP-1 receptor agonists and uses thereof Grant 10,934,279 - Aspnes , et al. March 2, 2 | 2021-03-02 |
Glp-1 Receptor Agonists And Uses Thereof App 20210047298 - Aspnes; Gary Erik ;   et al. | 2021-02-18 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors App 20200377482 - Dowling; Matthew ;   et al. | 2020-12-03 |
GLP-1 receptor agonists and uses thereof Grant 10,851,081 - Aspnes , et al. December 1, 2 | 2020-12-01 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Grant 10,787,438 - Dowling , et al. September 29, 2 | 2020-09-29 |
Glp-1 Receptor Agonists And Uses Thereof App 20200255406 - Kind Code | 2020-08-13 |
GLP-1 receptor agonists and uses thereof Grant 10,683,281 - Aspnes , et al. | 2020-06-16 |
Diacylglycerol Acyl Transferase 2 Inhibitors App 20200181127 - Boehm; Markus ;   et al. | 2020-06-11 |
GLP-1 receptor agonists and uses thereof Grant 10,676,465 - Aspnes , et al. | 2020-06-09 |
GLP-1 receptor agonists and uses thereof Grant 10,669,259 - Aspnes , et al. | 2020-06-02 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors App 20200148669 - Dowling; Matthew ;   et al. | 2020-05-14 |
GLP-1 Receptor Agonists and Uses Thereof App 20190382384 - Aspnes; Gary Erik ;   et al. | 2019-12-19 |
GLP-1 Receptor Agonists and Uses Thereof App 20190382387 - Aspnes; Gary Erik ;   et al. | 2019-12-19 |
GLP-1 Receptor Agonists and Uses Thereof App 20190382388 - Aspnes; Gary Erik ;   et al. | 2019-12-19 |
GLP-1 Receptor Agonists and Uses Thereof App 20190119255 - Aspnes; Gary Erik ;   et al. | 2019-04-25 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors App 20190106412 - Dowling; Matthew ;   et al. | 2019-04-11 |
GLP-1 receptor agonists and uses thereof Grant 10,208,019 - Aspnes , et al. Feb | 2019-02-19 |
Diacylglycerol acyltransferase 2 inhibitors Grant 10,188,653 - Futatsugi Ja | 2019-01-29 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Grant 10,174,007 - Dowling , et al. J | 2019-01-08 |
Diacylglycerol Acyl Transferase 2 Inhibitors App 20180258081 - Boehm; Markus ;   et al. | 2018-09-13 |
Diacylglycerol acyl transferase 2 inhibitors Grant 10,071,992 - Boehm , et al. September 11, 2 | 2018-09-11 |
GLP-1 Agonists and Uses Thereof App 20180170908 - Aspnes; Gary Erik ;   et al. | 2018-06-21 |
Diacylglycerol Acyl Transferase 2 Inhibitors App 20180051012 - Boehm; Markus ;   et al. | 2018-02-22 |
Diacylglycerol Acyltransferase 2 Inhibitors App 20180042926 - Futatsugi; Kentaro | 2018-02-15 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors App 20180037575 - Dowling; Matthew ;   et al. | 2018-02-08 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Grant 9,809,579 - Dowling , et al. November 7, 2 | 2017-11-07 |
Diacylglycerol acyltransferase 2 inhibitors Grant 9,789,110 - Futatsugi October 17, 2 | 2017-10-17 |
Antagonists of prostaglandin EP3 receptor Grant 9,738,626 - Bahnck , et al. August 22, 2 | 2017-08-22 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors App 20170183328 - Dowling; Matthew ;   et al. | 2017-06-29 |
Diacylglycerol Acyltransferase 2 Inhibitors App 20160303125 - CABRAL; SHAWN ;   et al. | 2016-10-20 |
Diacylglycerol acyltransferase 2 inhibitors Grant 9,440,949 - Cabral , et al. September 13, 2 | 2016-09-13 |
Antagonists Of Prostaglandin Ep3 Receptor App 20160176851 - Bahnck; Kevin ;   et al. | 2016-06-23 |
Diacylglycerol acyltransferase 2 inhibitors Grant 9,296,745 - Ahn , et al. March 29, 2 | 2016-03-29 |
Antagonists of prostaglandin EP3 receptor Grant 9,278,953 - Bahnck , et al. March 8, 2 | 2016-03-08 |
Diacylglycerol Acyltransferase 2 Inhibitors App 20150259323 - CABRAL; SHAWN ;   et al. | 2015-09-17 |
Antagonists Of Prostaglandin Ep3 Receptor App 20150099782 - Bahnck; Kevin Barry ;   et al. | 2015-04-09 |
Diacylglycerol Acyltransferase 2 Inhibitors App 20150087585 - Ahn; Kay ;   et al. | 2015-03-26 |
3-oxa-7-azabicyclo[3.3.1]nonanes App 20120095028 - DeNinno; Michael Paul ;   et al. | 2012-04-19 |
Gpr 119 Modulators App 20120052130 - Darout; Etzer ;   et al. | 2012-03-01 |
Morpholine Compounds App 20110281854 - Casimiro-Garcia; Agustin ;   et al. | 2011-11-17 |
Substituted bicyclocarboxyamide compounds Grant 7,964,732 - Ando , et al. June 21, 2 | 2011-06-21 |
Gpr 119 Modulators App 20100285145 - Darout; Etzer ;   et al. | 2010-11-11 |
Substituted Bicyclocarboxyamide Compounds App 20100267769 - Ando; Koji ;   et al. | 2010-10-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.